New video: Every peptide question my listeners sent in this past month. Answered.
00:00 Kisspeptin on TRT for women
04:20 PCOS in teens and early 20s
07:09 Dihexa for Alzheimer's 11:35 Retatrutide vs tirzepatide max dose
12:35 MOTS-C non-responders
23:57 GHK and AHK for hair loss
28:51 Yearly bioregulator cycling
32:43 Can thymosin alpha-1 spike CRP
37:08 Tesamorelin optimal dosing
Watch more → https://t.co/OtQs1WRE7X
🚨 HOLY CRAP! Nick Shirley FOLLOWED the California Speaker of the House and a Senator for pushing the Stop Nick Shirley Act, which CRIMINALIZES anti-fraud journalism
They were stumbling, panicked, REFUSING to acknowledge that levying up to $50K fines for journalism is TYRANNY
SHIRLEY: "Speaker Rivas...AB 2624? Is there a conflict of interest with Mia Bonta, and her husband being the ATTORNEY GENERAL?"
RIVAS: "I don't know." *Runs into car* 🤯
SHIRLEY: "These people won't even answer the questions."
@BLADES326@JonahLupton I stay up to date on research peptide vendors. Updated certificate of authenticity COA’s matters. It’s wise to be cautious about sourcing and avoid public discussions of specific suppliers. DM me for more info.
I'm on the peptide train.
After a week of BPC-157 (8 injections, 500mcg subcutaneous abdominal), persistent ankle tendon pain from a snowboarding injury a year ago is barely noticeable, and ankle mobility is significantly improved.
Chronic tech neck and shoulder pain is also much less present. No other significant lifestyle changes. Will still be on this cycle another 11 weeks, but seems positive with no observable side effects so far.
Yesterday I added TB-500 (1 injection, 2mg) as well, and in a week or two, I plan to add GHK-Cu assuming the first two are well-tolerated. I also plan to move to local injections of BPC-157 near injury sites while continuing systemically.
Exactly this. 👏
Peptides aren’t a trend, they’re a clinical tool, and sourcing + oversight matter.
That’s why I always stress guidance first, not hype. Licensed 503A compounding pharmacy, third-party testing for sterility, stability, and potency, and medical oversight through telehealth or a functional/clinical provider.
Quality over convenience is the standard, not the upgrade.